Mu-opioid antagonists for opioid-induced bowel dysfunction
about
Alvimopan for recovery of bowel function after radical cystectomyLaxatives or methylnaltrexone for the management of constipation in palliative care patientsTime course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapyEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionManaging opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide.Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation.Recent advances in the use of opioids for cancer painMethylnaltrexone in the treatment of opioid-induced constipationEffects of casoxin 4 on morphine inhibition of small animal intestinal contractility and gut transit in the mouseDivergent Effect of Dezocine, Morphine and Sufentanil on Intestinal Motor Function in Rats.Alvimopan for recovery of bowel function after radical cystectomy.Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients.Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems.The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilitiesCancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study.Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients.Clinical practice guideline for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons (ASCRS) and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
P2860
Q24186081-811D635E-E62E-4069-962D-D247FCB7E2FBQ24234823-929094DF-F207-46B8-9912-EBE061BBF9BFQ26863511-29325C13-B7F9-47E4-BEE6-636A4CB91D69Q27010907-49C68887-B0FE-4D53-ADEA-040B1F702C89Q33715430-F34B07D8-35CD-4176-9C72-86FF07C27AC1Q33973870-5AB50121-EA05-43BE-B67D-BB9A90772239Q34418203-D810F785-D4C9-4425-B954-88ECACBC4C1BQ35026245-CAFA4475-7542-4893-AAD5-786344B37577Q35026392-220B2C8D-8D78-4CDF-A486-49AA67A1AEB4Q36274984-FB91913A-E043-4060-A78E-DFC5A40495A4Q36360289-376895D9-96A5-472B-B6F1-057B89904C38Q37686927-7687B2D0-05CF-4A13-9995-EBD2D18EA7C2Q37981888-11716125-0BA3-4F57-87C0-90FD533A1F5BQ38116004-B09C7A2C-0B36-4591-BE04-04FF46C563B5Q39256745-E92866FC-7568-446F-80AD-9225E2A295ECQ43191518-F7FA2456-A5B8-40C0-9919-C4E2638062A5Q44071872-CBF20D6B-A342-4B5B-BC44-A38C96E9A919Q44340121-7501DF0C-62C3-4D68-98A3-15B2D9ADCB64
P2860
Mu-opioid antagonists for opioid-induced bowel dysfunction
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Mu-opioid antagonists for opioid-induced bowel dysfunction
@ast
Mu-opioid antagonists for opioid-induced bowel dysfunction
@en
Mu-opioid antagonists for opioid-induced bowel dysfunction
@en-gb
Mu-opioid antagonists for opioid-induced bowel dysfunction
@nl
type
label
Mu-opioid antagonists for opioid-induced bowel dysfunction
@ast
Mu-opioid antagonists for opioid-induced bowel dysfunction
@en
Mu-opioid antagonists for opioid-induced bowel dysfunction
@en-gb
Mu-opioid antagonists for opioid-induced bowel dysfunction
@nl
prefLabel
Mu-opioid antagonists for opioid-induced bowel dysfunction
@ast
Mu-opioid antagonists for opioid-induced bowel dysfunction
@en
Mu-opioid antagonists for opioid-induced bowel dysfunction
@en-gb
Mu-opioid antagonists for opioid-induced bowel dysfunction
@nl
P2093
P2860
P1476
Mu-opioid antagonists for opioid-induced bowel dysfunction
@en
P2093
Daniel B Carr
David Boyce
Ewan D McNicol
Roman Schumann
P2860
P356
10.1002/14651858.CD006332.PUB2
P577
2008-04-23T00:00:00Z